Harbour Investments’s VanEck Biotech ETF BBH Stock Holding History

Harbour Investments’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.2K	Sell	182 -13	-7%	-$2.5K	﹤0.01%	2555
2025 Q4	$36.9K	Hold	195	–	–	﹤0.01%	2107
2025 Q3	$32.3K	Sell	195 -40	-17%	-$6.52K	﹤0.01%	2099
2025 Q2	$36K	Hold	235	–	–	﹤0.01%	1965
2025 Q1	$37K	Hold	235	–	–	﹤0.01%	1921
2024 Q4	$36.9K	Hold	235	–	–	﹤0.01%	1858
2024 Q3	$41.7K	Hold	235	–	–	﹤0.01%	1754
2024 Q2	$39.6K	Hold	235	–	–	﹤0.01%	1669
2024 Q1	$39.1K	Sell	235 -15	-6%	-$2.48K	﹤0.01%	1642
2023 Q4	$41.3K	Hold	250	–	–	﹤0.01%	1550
2023 Q3	$38.9K	Sell	250 -26	-9%	-$4.15K	﹤0.01%	1462
2023 Q2	$43.1K	Buy	276 +232	+527%	+$37.1K	﹤0.01%	1430
2023 Q1	$7.13K	Hold	44	–	–	﹤0.01%	2154
2022 Q4	$7.03K	Sell	44 -21	-32%	-$3.33K	﹤0.01%	2105
2022 Q3	$9K	Hold	65	–	–	﹤0.01%	1953
2022 Q2	$9K	Buy	+65	New	+$9.68K	﹤0.01%	1953
2021 Q4	$37K	Sell	197 -564	-74%	-$109K	﹤0.01%	1388
2021 Q3	$154K	Buy	761 +440	+137%	+$92.4K	﹤0.01%	1148
2021 Q2	$65K	Buy	321 +42	+15%	+$7.82K	﹤0.01%	1647
2021 Q1	$49K	Buy	+279	New	+$50.5K	﹤0.01%	1709

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Harbour Investments's BBH Position: Q1 2026 in Review

Harbour Investments reduced its VanEck Biotech ETF (BBH) stake by 6.7% in Q1 2026, selling an estimated $2.5K and leaving 182 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Harbour Investments first reported a position in BBH in Q1 2021 and has held it in 20 quarters since. The position peaked at $154K in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Harbour Investments held 182 shares of VanEck Biotech ETF worth $34.2K as of Q1 2026.
Harbour Investments sold 13 VanEck Biotech ETF shares in Q1 2026, an estimated $2.5K.
VanEck Biotech ETF made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #2555 holding.
Harbour Investments first reported a position in VanEck Biotech ETF in Q1 2021 and has held it in 20 quarters since.
Harbour Investments's VanEck Biotech ETF position peaked at $154K in Q3 2021.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.